美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ORUKA THERAPEUTICS INC

10.35

-0.1000-0.96%

成交量：6.62万

成交额：67.33万

市值：3.88亿

市盈率：-2.45

高：10.65

开：10.65

低：9.90

收：10.45

数据加载中...

总览公司新闻公告

公司资料

公司名字：

ORUKA THERAPEUTICS INC

交易所：

NASDAQ

成立时间：

- -

员工人数：

28

公司地址：

855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States

官网：

http://orukatx.com

邮编：

94025

电话：

传真：

- -

简介：

Oruka Therapeutics, Inc.公司根据日期为2008年9月24日的协议和合并重组计划的条款完成了与ARCA Colorado的业务合并（合并），并于2008年10月28日进行了修订，其中Nuvelo，Inc.的全资子公司与ARCA Colorado合并，ARCA Colorado在合并后继续作为存续公司和Nuvelo，Inc.的全资子公司。紧随合并后，该公司从Nuvelo，Inc.更名为ARCA Biopharma，Inc.。Nuvelo最初注册成立为HYSEQ。该公司是一家临床阶段的生物制药公司，专注于开发针对银屑病、炎症和免疫学适应症的新型单克隆抗体疗法。

董事

名称

职位

Michael R. Bristow

President and Chief Executive Officer and Director

Robert E. Conway

Director, Chairman

Anders Hove

Director

Dan J. Mitchell

Director

Jacob Ma Weaver

Director

James Flynn

Director

Linda Grais

Director

Raymond L. Woosley

Director

股东

名称

职位

Michael R. Bristow

President and Chief Executive Officer and Director

Thomas A. Keuer

Chief Operating Officer

C. Jeffrey Dekker

Chief Financial Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ORKA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":10.35,"timestamp":1746036518717,"preClose":10.45,"halted":0,"volume":66222,"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"交易中","change":-0.1,"latestTime":"04-30 14:08:51 EDT","open":10.65,"high":10.65,"low":9.9,"amount":673331.72049,"amplitude":0.07177,"askPrice":10.37,"askSize":182,"bidPrice":10.34,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":10.45,"preHourTrading":{"tag":"盘前","latestPrice":9.85,"preClose":10.45,"latestTime":"08:41 EDT","volume":562,"amount":5745.659828,"timestamp":1746016864981},"postHourTrading":{"tag":"盘后","latestPrice":10.45,"preClose":10.45,"latestTime":"16:05 EDT","volume":899,"amount":9394.55,"timestamp":1745957105743},"volumeRatio":0.513668,"impliedVol":0.7944,"impliedVolPercentile":0.6222},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.513668,"shares":37440510,"dividePrice":0,"high":10.65,"amplitude":0.07177,"preClose":10.45,"low":9.9,"week52Low":5.485,"pbRate":"1.02","week52High":53.88,"institutionHeld":0.0223,"latestPrice":10.35,"committee":-0.925926,"eps":-4.225857,"divideRate":0,"volume":66222,"delay":0,"ttmEps":-4.225857,"open":10.65,"prevYearClose":19.39,"prevWeekClose":10.09,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":10.58,"twentyDayClose":9.56,"sixtyDayClose":13.7},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1877171755,"employeeNum":28,"address":"855 Oak Grove Avenue,Suite 100,Menlo Park,California,United States","zipCode":"94025","officePhone":"(650) 606-7910"},"stockCompanyDetail":{"websiteUrl":"http://orukatx.com","stockEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":-0.164},{"period":"3month","weight":-0.1342},{"period":"6month","weight":-0.6268},{"period":"1year","weight":-0.7461},{"period":"ytd","weight":-0.4611}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oruka Therapeutics, Inc.公司根据日期为2008年9月24日的协议和合并重组计划的条款完成了与ARCA Colorado的业务合并（合并），并于2008年10月28日进行了修订，其中Nuvelo，Inc.的全资子公司与ARCA Colorado合并，ARCA Colorado在合并后继续作为存续公司和Nuvelo，Inc.的全资子公司。紧随合并后，该公司从Nuvelo，Inc.更名为ARCA Biopharma，Inc.。Nuvelo最初注册成立为HYSEQ。该公司是一家临床阶段的生物制药公司，专注于开发针对银屑病、炎症和免疫学适应症的新型单克隆抗体疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":0.038367},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.074511},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.027833},{"month":4,"riseRate":0.588235,"avgChangeRate":0.096329},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.014024},{"month":8,"riseRate":0.0625,"avgChangeRate":-0.146138},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.080322},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.053682},{"month":11,"riseRate":0.625,"avgChangeRate":0.003334},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003439}],"exchange":"NASDAQ","name":"ORUKA THERAPEUTICS INC","nameEN":"ORUKA THERAPEUTICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Robert E. Conway","position":"Director, Chairman"},{"name":"Anders Hove","position":"Director"},{"name":"Dan J. Mitchell","position":"Director"},{"name":"Jacob Ma Weaver","position":"Director"},{"name":"James Flynn","position":"Director"},{"name":"Linda Grais","position":"Director"},{"name":"Raymond L. Woosley","position":"Director"}],"executives":[{"name":"Michael R. Bristow","position":"President and Chief Executive Officer and Director"},{"name":"Thomas A. Keuer","position":"Chief Operating Officer"},{"name":"C. Jeffrey Dekker","position":"Chief Financial Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-28","current":-4.136132,"percent":0.558824,"low":-5.124049,"twenty":-4.788731,"median":-4.205819,"eighty":-3.474515,"high":-2.779284,"avg":-4.125758,"sd":0.680287,"marketCap":377774745},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-04-28","current":-4.136132,"twenty":-4.788731,"median":-4.205819,"eighty":-3.474515,"marketCap":377774745}],"updateTime":1746000170443}}}